iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionPacific Center for Financial Services
Latest Disclosed Ownership623 shares
Latest Disclosed Value $ 105,239
Pacific Center for Financial Services reports 0.16% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 12, 2026 - Pacific Center for Financial Services filed a 13F-HR form disclosing ownership of 623 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $105,239 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 622 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.16% during the quarter. The current value of the position is $81,644 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 623 1 0.16 105 17.98 0.0267
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 622 0 0.00 90 0.00 0.0229
2025-11-13 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 622 0 0.00 90 14.10 0.0229
2025-08-18 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 622 0 0.00 79 -1.27 0.0213
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 622 1 0.16 80 -3.66 0.0211
2025-02-18 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 621 0 0.00 82 -8.89 0.0211
2024-11-15 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 621 1 0.16 90 5.88 0.0238
2024-08-15 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 620 0 0.00 85 0.00 0.0239
2024-05-20 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 620 108 21.09 85 23.19 0.0243
2024-02-20 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 512 1 0.20 70 11.29 0.0219
2023-11-15 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 511 -677 -56.99 62 -58.67 0.0212
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,188 0 0.00 151 -1.96 0.0496
2023-05-16 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,188 3 0.25 153 10.07 0.0529
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,185 0 0.00 139 0.00 0.0544
2022-08-12 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,185 1 0.08 139 -9.74 0.0573
2022-05-10 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,184 1 0.08 154 -14.92 0.0551
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,183 1 0.08 181 -5.24 0.0729
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,182 108 10.06 191 8.52 0.0833
2021-08-16 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,074 77 7.72 176 17.33 0.0768
2021-05-17 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 997 48 5.06 150 4.17 0.0718
2021-02-18 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 949 67 7.60 144 21.01 0.0533
2020-11-03 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 882 1 0.11 119 -0.83 0.0493
2020-08-06 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 881 54 6.53 120 34.83 0.0591
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 827 50 6.44 89 -5.32 0.0563
2020-02-13 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 777 109 16.32 94 42.42 0.0413
2019-11-14 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 668 63 10.41 66 0.00 0.0323
2019-08-15 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 605 397 190.87 66 186.96 0.0338
2019-05-16 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 208 0 0.00 23 15.00 0.0124
2019-02-19 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 208 0 0.00 20 -20.00 0.0107
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 208 1 0.48 25 8.70 0.0122
2018-08-13 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 207 0 0.00 23 4.55 0.0135
2018-05-08 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 207 0 0.00 22 0.00 0.0134
2018-02-15 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 207 138 200.00 22 -4.35 0.0135
2017-11-14 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 69 0 0.00 23 9.52 0.0147
2017-08-11 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 69 0 0.00 21 5.00 0.0141
2017-05-25 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 69 -271 -79.71 20 -77.78 0.0140
2017-02-16 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 340 340 90 0.0684
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.